Seahorse Bio, Moffitt Cancer Center Nab SBIR Contract to Measure 3D Tissue Metabolism

 

Exiqon Posts 17 Percent Revenue Growth for Q3

 

BioFire Defense Receives Emergency Use Authorization for Two FilmArray Ebola Tests

 

NCCN Mentions Prolaris, Oncotype DX in Updated Prostate Cancer Guidelines

 

Exact Sciences Reports No Revenues for Q3 as Firm Begins Commercialization of Cologuard Test

 

Most Viewed Articles on GWDN Last Week

 

NCCN Including Use of VeriStrat in NSCLC Guidelines

 

Amoy Diagnostics Obtains CE Mark for Cancer Mutation Assays

 

Seven Bridges Gets NCI Cloud Pilot Contract, Tailoring its Own AWS-based System for Cancer Research

 

BioDiscovery Enters New Market with Launch of Tailored Software for Clinical CNV